Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ROMULUS: Pinatuzumab vs Polatuzumab in r/r NHL
NCT01691898Phase 2Completed
- Sponsor
- Genentech
- Start
- Sep 2012
- Primary completion
- Mar 2017
- Modality
- Monoclonal Antibodies, Antibody-Drug Conjugates (ADCs)
- Countries
- 6
01
Overview
A Phase 2 trial of pinatuzumab vedotin, polatuzumab vedotin in follicular lymphoma (FL), diffuse large B-cell lymphoma (DLBCL), sponsored by Genentech. Started Sep 2012; status: completed.
02
Drugs
pinatuzumab vedotinpolatuzumab vedotin
03
Conditions
follicular lymphoma (FL)diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on NCT01691898.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01691898.